doxorubicin prodrugs (Bradford University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin prodrugs (Bradford University)
Drug Alias NameCCRL-1033
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitors
TargetsVirus DNA polymeraseTopoisomerase II
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bradford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Bradford
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A